Minaxi Jhawer
Overview
Explore the profile of Minaxi Jhawer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
730
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gordan J, Kennedy E, Abou-Alfa G, Beal E, Finn R, Gade T, et al.
J Clin Oncol
. 2024 Mar;
42(15):1830-1850.
PMID: 38502889
Purpose: To update an evidence-based guideline to assist in clinical decision-making for patients with advanced hepatocellular carcinoma (HCC). Methods: ASCO convened an Expert Panel to update the 2020 guideline on...
2.
Gordan J, Kennedy E, Abou-Alfa G, Beg M, Brower S, Gade T, et al.
J Clin Oncol
. 2020 Nov;
38(36):4317-4345.
PMID: 33197225
Purpose: To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with advanced hepatocellular carcinoma (HCC). Methods: ASCO convened an Expert Panel to conduct a...
3.
Klute K, Brouwer J, Jhawer M, Sachs H, Gangadin A, Ocean A, et al.
Eur J Cancer
. 2016 Jul;
63:189-200.
PMID: 27362999
Background: Malnutrition is prevalent in cancer patients and is associated with inferior outcomes. We examined the association between malnutrition, as measured by the Subjective Global Assessment (SGA), and chemotherapy dose...
4.
Shah M, Jhawer M, Ilson D, Lefkowitz R, Robinson E, Capanu M, et al.
J Clin Oncol
. 2010 Dec;
29(7):868-74.
PMID: 21189380
Purpose: To evaluate the safety and efficacy of a modified administration schedule of docetaxel, cisplatin, and fluorouracil (mDCF) with bevacizumab in patients with advanced gastroesophageal malignancies. Patients And Methods: Previously...
5.
Wilson A, Chueh A, Togel L, Corner G, Ahmed N, Goel S, et al.
Cancer Res
. 2010 Jan;
70(2):609-20.
PMID: 20068171
Histone deacetylase inhibitors (HDACi) induce growth arrest and apoptosis in colon cancer cells and are being considered for colon cancer therapy. The underlying mechanism of action of these effects is...
6.
Yuan Z, Shin J, Wilson A, Goel S, Ling Y, Ahmed N, et al.
Cancer Res
. 2009 Oct;
69(19):7811-8.
PMID: 19789347
Colorectal cancers (CRC) with microsatellite instability (MSI) have clinical, pathologic, genetic, and epigenetic features distinct from microsatellite-stable CRC. Examination of epidermal growth factor receptor (EGFR) mRNA and protein expression levels...
7.
Jhawer M, Coit D, Brennan M, Qin L, Gonen M, Klimstra D, et al.
Am J Clin Oncol
. 2009 Apr;
32(4):356-62.
PMID: 19381079
Background: We examined gene expression profiles and clinicopathologic features (tumor location, stage, graded pathologic response, perineural invasion (PNI), Lauren's classification, and survival) of patients with gastric cancer who received preoperative...
8.
Jhawer M, Kelsen D, Shah M
Gastrointest Cancer Res
. 2009 Apr;
1(2 Suppl):S22-9.
PMID: 19343157
Gastroesophageal malignancies are highly aggressive tumors with mortality rates remaining close to incidence rates; the majority of patients have advanced incurable disease at diagnosis. Although patients receive palliative benefit from...
9.
Jhawer M, Goel S, Wilson A, Montagna C, Ling Y, Byun D, et al.
Cancer Res
. 2008 Mar;
68(6):1953-61.
PMID: 18339877
Cetuximab is a monoclonal antibody that targets the human epidermal growth factor receptor (EGFR). Although approved for use in EGFR-overexpressing advanced colorectal cancer, recent studies have shown a lack of...
10.
Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, et al.
Invest New Drugs
. 2006 Sep;
25(1):85-94.
PMID: 16957834
Background: To evaluate the tolerability and efficacy of nolatrexed in patients with advanced hepatocellular carcinoma. Patients And Methods: Forty-eight patients were entered onto this study. Nolatrexed was administered every 3...